Vitasora Health (ASX:VHL) — Material Events

ASX:VHL · 11 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 9 articles Notable 2 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
9
Vitasora Accelerates US Growth with 22,458 Patient Programs and A$11M Capital RaiseMedium
Vitasora reports strong patient growth, new US partnerships, and A$11M capital raise
31 Oct 2025 ·Appendix 4C Quarterly Cash Flow and Activities Report ·85
Vitasora Accelerates Patient Growth with vCare Platform Rollout and Cost CutsMedium
Vitasora Executes vCare Rollout, Accelerates Patient Enrolments, Targets Cashflow Breakeven in H2 2026
18 May 2026 ·Operational Update ·85
Vitasora Boosts Daily Billing 22%, Eyes 20% Revenue Lift from CMS ChangesMedium
Vitasora reports 22% rise in daily billing, 17% revenue growth, and strong cash position amid CMS reimbursement gains
29 Jan 2026 ·Appendix 4C - Quarterly Cash Flow and Activities Report ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.